Procedure
vestibular migraine1 acoustic neuroma
HYPOFUNCTION
When a clinician identified a patient as eligible, they reviewed the informed consent and explained the study procedures. Following consent, patients underwent a baseline assessment including functional measures (Functional Gait Assessment [FGA] [
Description of the C.S.I, Contextual Sensory Integration /Traditional Sample on Pre-treatment VariablesFemale = 18 (60.00%)Male = 12 (40.00%)Female = 9 (60.00%)Male = 6 (40.00%)Female = 9 (60.00%)Male = 6 (40.00%)Abnormal = 12 (40.00%)Normal = 15 (50.00%)NT = 3 (10.00%)Abnormal = 6 (40.00%)Normal = 9 (60.00%)Abnormal = 6 (40.00%)Normal = 6 (40.00%)NT = 3 (20.00%)Abnormal = 11 (36.67%)Normal = 17 (56.67%)NT = 2 (6.67%)Abnormal = 5 (33.33%)Normal = 10 (66.67%)Abnormal = 6 (40.00%)Normal = 7 (46.67%)NT = 2 (13.33%)Abnormal = 8 (26.67%)Normal = 21 (70.00%)NT = 1 (3.33%)Abnormal = 1 (6.67%)Normal = 14 (93.33%)Abnormal = 7 (46.67%)Normal = 7 (46.67%)NT = 1 (6.67%)No = 19 (63.33%)Yes = 11 (36.67%)No = 11 (73.33%)Yes = 4 (26.67%)No = 8 (53.33%)Yes = 7 (46.67%)Normal = 3 (10.00%)Weakness = 16(53.33%)NT = 11 (36.67%)Normal = 2 (13.33%)Weakness = 7 (46.67%)NT = 6 (40.00%)Normal = 1 (6.67%)Weakness: 9 (60.00%)NT = 5 (33.33%)24/30 peripheral hypofunction2 post-concussion2 vestibular migraine2 acoustic neuroma11 peripheral hypofunction1 post-concussion2 vestibular migraine1 acoustic neuroma13 peripheral hypofunction1 post-concussion0 vestibular migraine1 acoustic neuroma#: One way ANOVA, Analysis of Variance; ##: Chi-square for proportions; ###: Kruskal-WallisNT: Not Tested